505 related articles for article (PubMed ID: 26678864)
1. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
[TBL] [Abstract][Full Text] [Related]
2. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
[TBL] [Abstract][Full Text] [Related]
3. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
[TBL] [Abstract][Full Text] [Related]
4. Early grey matter changes in structural covariance networks in Huntington's disease.
Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Poudel GR; Stout JC; DomÃnguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
[TBL] [Abstract][Full Text] [Related]
6. Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
DomÃnguez D JF; Egan GF; Gray MA; Poudel GR; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
PLoS One; 2013; 8(9):e74131. PubMed ID: 24066104
[TBL] [Abstract][Full Text] [Related]
7. Regional subcortical shape analysis in premanifest Huntington's disease.
Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
[TBL] [Abstract][Full Text] [Related]
8. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
9. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
[TBL] [Abstract][Full Text] [Related]
10. Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study.
Turner LM; Jakabek D; Wilkes FA; Croft RJ; Churchyard A; Walterfang M; Velakoulis D; Looi JC; Georgiou-Karistianis N; Apthorp D
Brain Behav; 2016 Dec; 6(12):e00511. PubMed ID: 28031992
[TBL] [Abstract][Full Text] [Related]
11. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
12. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
[TBL] [Abstract][Full Text] [Related]
13. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.
McColgan P; Seunarine KK; Razi A; Cole JH; Gregory S; Durr A; Roos RA; Stout JC; Landwehrmeyer B; Scahill RI; Clark CA; Rees G; Tabrizi SJ;
Brain; 2015 Nov; 138(Pt 11):3327-44. PubMed ID: 26384928
[TBL] [Abstract][Full Text] [Related]
14. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
Sweidan W; Bao F; Bozorgzad NS; George E
J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
[TBL] [Abstract][Full Text] [Related]
15. Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.
Misiura MB; Ciarochi J; Vaidya J; Bockholt J; Johnson HJ; Calhoun VD; Paulsen JS; Turner JA;
J Int Neuropsychol Soc; 2019 May; 25(5):462-469. PubMed ID: 30806337
[TBL] [Abstract][Full Text] [Related]
16. Local synchronicity in dopamine-rich caudate nucleus influences Huntington's disease motor phenotype.
Kasper J; Eickhoff SB; Caspers S; Peter J; Dogan I; Wolf RC; Reetz K; Dukart J; Orth M
Brain; 2023 Aug; 146(8):3319-3330. PubMed ID: 36795496
[TBL] [Abstract][Full Text] [Related]
17. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
[TBL] [Abstract][Full Text] [Related]
18. Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.
Furukawa F; Ishikawa K; Yokota T; Sanjo N
Eur Neurol; 2019; 81(1-2):13-18. PubMed ID: 31013498
[TBL] [Abstract][Full Text] [Related]
19. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
Chen L; Hua J; Ross CA; Cai S; van Zijl PCM; Li X
J Neurosci Res; 2019 Apr; 97(4):467-479. PubMed ID: 30489648
[TBL] [Abstract][Full Text] [Related]
20. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.
Kipps CM; Duggins AJ; Mahant N; Gomes L; Ashburner J; McCusker EA
J Neurol Neurosurg Psychiatry; 2005 May; 76(5):650-5. PubMed ID: 15834021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]